Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Neurovations
company
About
Neurovations is a patient care and innovation company.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $6.90M
- Industries
- Health Care
- Founded date
- Nov 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Neurovations is to create medical devices that shorten hospitalization and increase patient satisfaction while providing efficacious care. It is an early stage medical device company seeking to create minimal intracranial access devices for the removal of pathology and the insertion of diagnostic and diagnostic devices. It is developing a novel device for the evacuation of intracranial hemorrhage.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$6.90M
Neurovations has raised a total of
$6.90M
in funding over 2 rounds. Their latest funding was raised on
Oct 13, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 13, 2022 | Grant | $6.90M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Neurovations is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
